Zoetis' Breakthrough Avian Flu Vaccine Gets USDA Approval — What It Means for the Future of Poultry and Egg Prices!
In a major step toward combating the ongoing avian flu outbreak, Zoetis has received conditional approval from the U.S. Department of Agriculture (USDA) for its avian flu vaccine, designed specifically for chickens. The approval comes as the U.S. faces a devastating bird flu epidemic that has ravaged poultry flocks and led to skyrocketing egg prices.
Vetscan Imagyst Unveils New AI Masses Technology for Faster Cancer Detection in Veterinary Clinics
Zoetis Inc., the world’s leading animal health company, has today announced a new Vetscan Imagyst capability, AI Masses, which uses best-in-class AI to analyze potentially neoplastic cells in lymph node and subcutaneous lesions. This addition offers veterinary health teams the ability to make more informed treatment decisions, improve clinic efficiency, elevate pet owners’ experience and expand access to care for pets.
Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain
Since its launch in Europe four years ago, Librela has improved the lives of millions of dogs suffering from OA pain. With nearly 25 million doses1 distributed globally, no individual adverse event sign has been reported at a rate higher than rare, as defined by the European Medicines Agency (EMA) – representing less than 10 occurrences per 10,000 treated animals (where one dose equals one treated animal)2 .
FDA Approves New Label Indications for Zoetis' Simparica Trio®, Simparica® Chewables, and Revolution® Plus
Simparica Trio® and Simparica® Chewables now include the treatment and control of infestations with the Asian longhorned tick (Haemaphysalis longicornis) in dogs.
Zoetis Takes the Lead in Veterinary AI Diagnostics with Major Vetscan Imagyst Enhancements
Zoetis, the world leader in animal health, has announced groundbreaking upgrades to its Vetscan Imagyst digital microscopy platform, solidifying its position as a trailblazer in veterinary AI diagnostics. These cutting-edge enhancements across multiple testing applications promise to revolutionize veterinary care, providing faster, more accurate results and empowering veterinarians with the tools needed for individualized patient care.
Zoetis Announces Partnership with Arthritis Foundation to Raise Awareness of Osteoarthritis Pain in Pets
Today, in recognition of Pain Awareness Month, Zoetis and the Arthritis Foundation have announced a two-year partnership to raise awareness of and provide educational resources about the most common type of arthritis pain, known as osteoarthritis (OA) pain. While OA in humans is well-known, many people are not aware of how common OA – and the pain it causes – is in cats and dogs.